Gainers
ASLAN Pharma (NASDAQ:ASLN) stock moved upwards by 13.7% to $0.54 during Wednesday's after-market session. The market value of their outstanding shares is at $37.6 million.
Enliven Therapeutics Inc and Imara Inc (NASDAQ:IMRA) agreed to merge in an all-stock transaction. The combined company will focus on advancing Enliven’s…
Enliven Therapeutics, Inc. (Enliven), a clinical-stage precision oncology company focused on the discovery and development of next-generation small molecule kinase inhibitors, and Imara Inc. (NASDAQ:IMRA) (Imara) today